Trial Profile
Safety and efficacy of substitution with a novel once-daily extended-release tacrolimus (LCPT;Envarsus®)to immediate-release tacrolimus (IR-Tac, Prograf®) twice daily in liver transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2018 New trial record
- 06 Jun 2018 Results presented at the 2018 American Transplant Congress